Have a feature idea you'd love to see implemented?
Let us know!
FBIO Fortress Biotech Inc
Price (delayed)
$1.57
Market cap
$43.34M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.05
Enterprise value
$52.7M
Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in
Highlights
Fortress Biotech's EPS has surged by 76% YoY and by 6% QoQ
The company's equity rose by 27% YoY and by 18% QoQ
FBIO's net income is up by 38% YoY but it is down by 19% QoQ
FBIO's quick ratio is up by 20% YoY but it is down by 14% QoQ
The gross profit has declined by 33% since the previous quarter and by 28% year-on-year
FBIO's revenue is down by 24% since the previous quarter and by 23% year-on-year
Key stats
What are the main financial stats of FBIO
Market
Valuations
Earnings
Shares outstanding
27.6M
Market cap
$43.34M
Enterprise value
$52.7M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.69
Price to sales (P/S)
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.84
Revenue
$62.5M
EBIT
-$35.07M
EBITDA
-$27.66M
Free cash flow
-$102.25M
Per share
Balance sheet
Liquidity
EPS
-$3.05
Free cash flow per share
-$5.19
Book value per share
$0.93
Revenue per share
$3.17
TBVPS
$5.55
Total assets
$127.09M
Total liabilities
$139.82M
Debt
$70.28M
Equity
$21.16M
Working capital
$15.97M
Debt to equity
3.32
Current ratio
1.23
Quick ratio
1.02
Net debt/EBITDA
-0.34
Margins
Efficiency
Dividend
EBITDA margin
-44.2%
Gross margin
60.5%
Net margin
-77.6%
Operating margin
-169.7%
Return on assets
-38%
Return on equity
-271.4%
Return on invested capital
-61.3%
Return on capital employed
-61.8%
Return on sales
-56.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FBIO stock price
How has the Fortress Biotech stock price performed over time
Intraday
0%
1 week
0%
1 month
-11.8%
1 year
-28.64%
YTD
-47.84%
QTD
8.65%
Financial performance
How have Fortress Biotech's revenue and profit performed over time
Revenue
$62.5M
Gross profit
$37.84M
Operating income
-$106.06M
Net income
-$48.51M
Gross margin
60.5%
Net margin
-77.6%
The net margin has shrunk by 58% QoQ but it has increased by 20% YoY
FBIO's operating margin is down by 43% since the previous quarter but it is up by 23% year-on-year
FBIO's operating income is up by 40% YoY but it is down by 9% from the previous quarter
FBIO's net income is up by 38% YoY but it is down by 19% QoQ
Growth
What is Fortress Biotech's growth rate over time
Valuation
What is Fortress Biotech stock price valuation
P/E
N/A
P/B
1.69
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.84
Fortress Biotech's EPS has surged by 76% YoY and by 6% QoQ
The P/B is 37% less than the 5-year quarterly average of 2.7 but 6% more than the last 4 quarters average of 1.6
The company's equity rose by 27% YoY and by 18% QoQ
The P/S is 80% below the 5-year quarterly average of 2.5 but 23% above the last 4 quarters average of 0.4
FBIO's revenue is down by 24% since the previous quarter and by 23% year-on-year
Efficiency
How efficient is Fortress Biotech business performance
Fortress Biotech's return on sales has shrunk by 50% QoQ but it has increased by 24% YoY
FBIO's return on invested capital is up by 48% year-on-year but it is down by 3.7% since the previous quarter
The ROA has declined by 21% since the previous quarter but it has grown by 2.3% year-on-year
The company's return on equity rose by 10% YoY but it fell by 10% QoQ
Dividends
What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FBIO.
Financial health
How did Fortress Biotech financials performed over time
The total assets is 9% less than the total liabilities
Fortress Biotech's current ratio has increased by 23% YoY but it has decreased by 10% from the previous quarter
FBIO's quick ratio is up by 20% YoY but it is down by 14% QoQ
The debt to equity has declined by 31% since the previous quarter and by 22% year-on-year
The company's equity rose by 27% YoY and by 18% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.